Felodipine Compared to Nifedipine as "Third-Line Drug" in Resistant Hypertension

Maclean, Derek; Thomson Mitchell, Elizabeth; Sandilands Readman, Ann
November 1986
Angiology;Nov1986, Vol. 37 Issue 11, p840
Academic Journal
Felodipine is a new dihydropyridine calcium antagonist, and in hypertension it is a much more effective "third-line" drug than hydralazine. Nifedipine, on the other hand, is the established dihydropyridine calcium antagonist that has been increasingly used to treat hypertension. Information is now needed on the relative merits and demerits of these two drugs. This study appraised, therefore, the therapeutic utility of twelve months' treatment with nifedipine 20-60 mg twice daily in 55 patients with previous drug-resistant hypertension who had been successfully treated for the previous year with felodipine 5-20 mg twice daily, each calcium antagonist being used in combination with atenolol 100 mg daily with or without chlorthalidone 25 mg daily. Initially, nifedipine maintained comparable blood pressure control to that which had been achieved by felodipine, although in the longer term (over eight months) nifedipine proved less effective than felodipine had (p < 0.02) and more patients became uncontrolled (supine diastolic blood pressure. Phase V, ≫ 90 mmHg) on the maximum tolerated dose of the calcium antagonist (χ²=4.13, p< 0.05 > 0.025). The former degree of blood pressure control was, however, reestablished by increasing the dose of nifedipine or reintroducing the diuretic as necessary, and this control was maintained over the next four months. Minor side effects were less common on nifedipine than they had been during the preceding felodipine treatment phase.


Related Articles

  • Management of Hypertension in Older Persons. Dickerson, Lori M.; Gibson, Maria V. // American Family Physician;2/1/2005, Vol. 71 Issue 3, p469 

    Antihypertensive therapy has been shown to reduce morbidity and mortality in older patients with elevated systolic or diastolic blood pressures. This benefit appears to persist in patients older than 80 years, but less than one third of older patients have adequate blood pressure control....

  • Latest guidelines: Blood pressure management. Thomas, Susan // Practice Nursing;Nov2012, Vol. 23 Issue 11, p570 

    The article offers the latest guidelines by the National Institute for Health and Clinical Excellence (NICE) for the clinical management of hypertension in adults, which includes the use of ambulatory blood pressure monitoring (ABPM), or home blood pressure monitoring (HBPM). A antihypertensive...

  • Are all fixed dose combinations equally effective in blood pressure control? The analysis of four different fixed dose antihypertensive combinations. Mesci, Banu; Tekin, Murat; Oguz, Aytekin; Celik, Selda; Kilic, Damla Coksert; Sagun, Gul; Turgut, Mustafa Kemal // Pakistan Journal of Medical Sciences;Jul2012, Vol. 28 Issue 3, p613 

    Objective: Hypertension guidelines recommend the use of fixed dose combinations as the first step treatment in patients with stage 2 and 3 hypertension. The aim of this study was to compare the antihypertensive effects of four different fixed-dose preparations containing beta blocker...

  • The 2014 hypertension guidelines: Processing the information. Gelatic, Randee // JAAPA: Journal of the American Academy of Physician Assistants (;Nov2014, Vol. 27 Issue 11, p15 

    Recent guidelines on hypertension management offer conflicting recommendations. This article describes the JNC 8 and ASH/ISH guidelines and the four medications recommended for controlling BP in various patient populations.

  • Physicians must individualize hypertension treatment. Zablocki, Elaine // Managed Healthcare Executive;May2004, Vol. 14 Issue 5, p52 

    Reports on the need to individualize the treatment for hypertension. Different classes of drugs that control hypertension; Advantage of diuretics over calcium channel blocker, and angiotensin-converting enzyme (ACE) inhibitor; Efficacy of ACE inhibitors in hypertensive patients with left...

  • How to Use Calcium Antagonists in Hypertension: Putting the JNC-VI Guidelines into Practice. Singh, V.; Christiana, J.; Frishman, W.H. // Drugs;Oct1999, Vol. 58 Issue 4, p579 

    The prevention and treatment of hypertension remain as major challenges for clinicians all over the world. The recently published Sixth Report of the Joint National Committee for the Prevention, Detection, Evaluation and Treatment of High Blood Pressure (JNC-VI) uses evidence-based medicine in...

  • Clinical Perspective On The Management Of Hypertension. Iqbal, Muzaffar // Indian Journal of Clinical Medicine;2011, Issue 2, p1 

    Hypertension is an important medical and public health issue all over the world. It is one of the most prevalent conditions seen today by clinicians in both developed and developing countries. Depending upon progression of systolic and diastolic blood pressure it is classified into stage 1, 2...

  • Fixed-Dose Combination Enalapril/Nitrendipine: A Review of its Use in Mild-to-Moderate Hypertension. Asif, M.; Siddiqui, A.; Plosker, Greg L. // Drugs;2004, Vol. 64 Issue 10, p1135 

    The fixed-dose combination of enalapril 10 mg with nitrendipine 20 mg combines an ACE inhibitor with a calcium channel antagonist (CCA) and is indicated for the treatment of patients with mild-to-moderate hypertension whose blood pressure (BP) is inadequately controlled with enalapril or...

  • Serum Calcium Level in Hypertension. Hazari, Mohammed Abdul Hannan; Arifuddin, Mehnaaz Sameera; Muzzakar, Syed; Reddy, Vontela Devender // North American Journal of Medical Sciences;Nov2012, Vol. 4 Issue 11, p569 

    Background: The alterations in extracellular calcium level may influence intracellular calcium level and possibly play a role in the pathogenesis of essential hypertension. Aim: The purpose was to find out the association between serum calcium levels and hypertension; and to compare the serum...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics